PHARMA TECHNOLOGY A/S: Financial statements 2018
CVR: 20826746
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 10,929,583 and a net result of DKK 3,536,660 compared with DKK 5,320,056 the year before. That is a decrease of 32.7% compared with the year before. Equity in the 2018 report amounted to DKK 4,036,660. The solvency ratio was 49.8%.
- Gross Profit
- DKK 10,929,583
- Profit/Loss
- DKK 3,536,660
- Equity
- DKK 4,036,660
- Total Assets
- DKK 8,103,347
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 10.9 mio. | 3.5 mio. | 4 mio. | - |
| 2017 | - | 16.2 mio. | 5.3 mio. | 5.8 mio. | - |
| 2016 | - | 18.5 mio. | 5.5 mio. | 6.6 mio. | 11 |
| 2015 | - | 10.6 mio. | 3.7 mio. | 4.8 mio. | 9 |
| 2014 | 24.5 mio. | 14.8 mio. | 4.6 mio. | 5.1 mio. | 11 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PHARMA TECHNOLOGY A/S has published its annual report for 2017. Gross profit came to DKK 16,233,914, and the net result was DKK 5,320,056.
As of March 19, 2018, Revisionskontoret i Faxe has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of March 19, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PHARMA TECHNOLOGY A/S.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.